

Tirzepatide Wholesale kit of 10 vials · research use only
- LY3298176
- Dual GIP / GLP-1 receptor agonist
- CAS 2023788-19-2
Tirzepatide is a 39-amino-acid synthetic peptide engineered to act on both the glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors. Its dual-agonist profile makes it a common reference compound in incretin receptor research.
Free shipping on orders over US$700, otherwise US$70.00 flat per order. Secure card payment link emailed after you order.
Prices are set in USD and shown in USD (). Exchange rates updated · .
Tirzepatide kit sizes and wholesale prices
| Size per vial | Kit contents | Price per kit |
|---|---|---|
| 5 mg | 10 vials | US$94.00 |
| 10 mg | 10 vials | US$110.00 |
| 15 mg | 10 vials | US$130.00 |
| 20 mg | 10 vials | US$140.00 |
| 30 mg | 10 vials | US$171.00 |
| 40 mg | 10 vials | US$203.00 |
| 50 mg | 10 vials | US$244.00 |
| 60 mg | 10 vials | US$280.00 |
| 100 mg | 10 vials | US$399.00 |
| 120 mg | 10 vials | US$467.00 |
About Tirzepatide
Tirzepatide is a 39-amino-acid synthetic peptide engineered to act on both the glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors. Its dual-agonist profile makes it a common reference compound in incretin receptor research.
Product details
- Product: Tirzepatide
- Also known as: LY3298176, Dual GIP / GLP-1 receptor agonist, CAS 2023788-19-2
- Category: Incretin & metabolic peptides
- Supplied as: kit of 10 vials, lyophilised powder
- Available sizes: 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 100 mg, 120 mg per vial
Related research peptides


Retatrutide
LY3437943 · Triple GIP / GLP-1 / glucagon receptor agonist


Cagrilintide + Semaglutide Blend
CagriSema · Amylin analogue + GLP-1 analogue blend